CME vs TRU

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

CME

45.0
AI Score
VS
CME Wins

TRU

38.0
AI Score

Investment Advisor Scores

CME

45score
Recommendation
HOLD

TRU

38score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric CME TRU Winner
Forward P/E 22.2222 14.9701 TRU
PEG Ratio 4.7658 1.1521 TRU
Revenue Growth 0.8% 14.9% TRU
Earnings Growth 2.5% 32.1% TRU
Tradestie Score 45.0/100 38.0/100 CME
Profit Margin 63.4% 15.1% CME
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL CME

Relative Price Performance (Last 90 Days)

CME 1M: +5.1% · 3M: +5.1% TRU 1M: -2.2% · 3M: +18.3%

Current Technical Phase

CME

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.9% over 20 days), RSI 53

RSI (14): 53.1 · Price: $275.54

TRU

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.6 · Price: $77.70

Fundamentals Snapshot

Metric CME TRU
Market Cap
Forward P/E 21.3 13.9
Trailing P/E 23.3 20.3
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 1.0% 0.6%
Operating Margin 0.7% 0.2%
EPS 11.78 3.79
Dividend Yield 0.02% 0.00%

Frequently Asked Questions

Based on our detailed analysis, CME is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.